GRI Bio (GRI) Assets (2020 - 2026)
GRI Bio's Assets was $11.38 million in Q2 2026, up 100.5% from $5.68 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
GRI Bio (GRI) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Assets at GRI Bio came in at $8.67 million, up 51.0% from FY2024.
- Assets has now increased for three consecutive years, with a five-year compound annual growth rate of 55.4% (FY2020 to FY2025).
- In earlier years, Assets was $5.74 million in FY2024 (+94.1%), $2.96 million in FY2023 (+671.8%), $383,000 in FY2022 (-95.4%) and $8.34 million in FY2021 (+772.8%).
- The Q2 2026 figure marks the highest quarterly Assets since Q2 2021.
- Compared with a year earlier, Assets has increased for three straight quarters, with growth averaging 50.8% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q4 2021 (growth of 772.8%); the worst was Q4 2022 (a decline of 95.4%).
- Per Business Quant data, GRI's Assets in the three quarters before Q2 2026 was $11.34 million (Q1 2026), $8.67 million (Q4 2025) and $4.78 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | GRI Bio | 3.79 Mn | 3.79 Mn | - | 11.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.38 Mn |
| Mar 31, 2026 | 11.34 Mn |
| Dec 31, 2025 | 8.67 Mn |
| Sep 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 5.68 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Dec 31, 2024 | 5.74 Mn |
| Sep 30, 2024 | 5.46 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Mar 31, 2024 | 4.59 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 5.64 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 383,000.00 |
| Sep 30, 2022 | 5.57 Mn |
| Jun 30, 2022 | 8.01 Mn |
| Mar 31, 2022 | 5.94 Mn |
| Dec 31, 2021 | 8.34 Mn |
| Sep 30, 2021 | 10.14 Mn |
API Access
GRI Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();